WO2005001059A3 - Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions - Google Patents
Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions Download PDFInfo
- Publication number
- WO2005001059A3 WO2005001059A3 PCT/US2004/020152 US2004020152W WO2005001059A3 WO 2005001059 A3 WO2005001059 A3 WO 2005001059A3 US 2004020152 W US2004020152 W US 2004020152W WO 2005001059 A3 WO2005001059 A3 WO 2005001059A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- carbon dioxide
- temperature conditions
- supercritical pressure
- organisms
- inactivating organisms
- Prior art date
Links
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title abstract 4
- 229910002092 carbon dioxide Inorganic materials 0.000 title abstract 2
- 239000001569 carbon dioxide Substances 0.000 title abstract 2
- 230000000415 inactivating effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0275—Salmonella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/07—Bacillus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/577,050 US7560113B2 (en) | 2003-06-23 | 2004-06-23 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
US12/480,107 US7919096B2 (en) | 2003-06-23 | 2009-06-08 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
US12/888,933 US8388944B2 (en) | 2003-06-23 | 2010-09-23 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48040603P | 2003-06-23 | 2003-06-23 | |
US60/480,406 | 2003-06-23 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/577,050 A-371-Of-International US7560113B2 (en) | 2003-06-23 | 2004-06-23 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
US12/480,107 Division US7919096B2 (en) | 2003-06-23 | 2009-06-08 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005001059A2 WO2005001059A2 (en) | 2005-01-06 |
WO2005001059A3 true WO2005001059A3 (en) | 2005-08-04 |
Family
ID=33551915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/020152 WO2005001059A2 (en) | 2003-06-23 | 2004-06-23 | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
Country Status (2)
Country | Link |
---|---|
US (3) | US7560113B2 (en) |
WO (1) | WO2005001059A2 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8034288B2 (en) * | 2003-06-23 | 2011-10-11 | Novasterilis | Method and apparatus for cleaning of viable donor soft tissue |
WO2005001059A2 (en) * | 2003-06-23 | 2005-01-06 | Novasterilis Inc. | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
US8974730B2 (en) | 2003-06-23 | 2015-03-10 | Novasterilis, Inc. | Process for creating acellular viable donor soft tissue |
US20080277092A1 (en) * | 2005-04-19 | 2008-11-13 | Layman Frederick P | Water cooling system and heat transfer system |
ES2423663T3 (en) | 2005-08-08 | 2013-09-23 | Oregon Health And Science University | Inactivation of pathogens with hydrogen peroxide for vaccine production |
WO2008000846A1 (en) * | 2006-06-19 | 2008-01-03 | Natraceutical S.A. | Method for sterilizing cocoa materials using supercritical co2 |
AU2009204952B2 (en) | 2008-01-18 | 2013-02-07 | Werner Lubitz | Bacterial ghost (BG) production process using betapropiolactone (BLP) for final inactivation |
US9649408B1 (en) | 2009-11-05 | 2017-05-16 | Lifecell Corporation | Systems and methods for sterilization of bone or bone components |
WO2012125955A2 (en) | 2011-03-16 | 2012-09-20 | Mayo Foundation For Medical Education And Research | Methods and materials for prolonging useful storage of red blood cell preparations and platelet preparations |
US9655373B2 (en) * | 2012-01-10 | 2017-05-23 | Novasterilis, Inc. | Method and apparatus for the sterilization of ground meat using supercritical CO2 |
US20140248328A1 (en) * | 2012-08-31 | 2014-09-04 | Jennifer L. Wehmeyer | Methods of treating amniotic membranes using supercritical fluids and compositions and apparatuses prepared therefrom |
US20170112945A1 (en) * | 2015-10-22 | 2017-04-27 | Novasterilis Inc. | Anchoring and/or Impregnation of Biological Vehicles with Cargo Molecules using a Subcritical or Supercritical Fluid |
WO2022109430A1 (en) * | 2020-11-22 | 2022-05-27 | Castor Trevor P | Sustained release inactivated vaccines |
WO2023063932A1 (en) * | 2021-10-12 | 2023-04-20 | Castor Trevor P | Continuous flow, high throughput apparatus and method for inactivating viruses and pathogens in human plasma |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6149864A (en) * | 1998-06-25 | 2000-11-21 | Massachusetts Institute Of Technology | Supercritical fluid sterilization method |
US20030108918A1 (en) * | 2001-09-05 | 2003-06-12 | Castor Trevor P. | Inactivated vaccines for aids and other infectious diseases |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4681839A (en) * | 1982-09-23 | 1987-07-21 | Swartz Mitchell R | Systems to preserve living tissue |
JP2663483B2 (en) * | 1988-02-29 | 1997-10-15 | 勝 西川 | Method of forming resist pattern |
FR2639233B1 (en) * | 1988-11-23 | 1994-05-06 | Air Liquide | HEMODIALYSIS HYGIENE AGENT |
US5213619A (en) * | 1989-11-30 | 1993-05-25 | Jackson David P | Processes for cleaning, sterilizing, and implanting materials using high energy dense fluids |
US5370740A (en) * | 1993-10-01 | 1994-12-06 | Hughes Aircraft Company | Chemical decomposition by sonication in liquid carbon dioxide |
US6613278B1 (en) * | 1998-11-13 | 2003-09-02 | Regeneration Technologies, Inc. | Tissue pooling process |
US6482584B1 (en) * | 1998-11-13 | 2002-11-19 | Regeneration Technologies, Inc. | Cyclic implant perfusion cleaning and passivation process |
US5996155A (en) * | 1998-07-24 | 1999-12-07 | Raytheon Company | Process for cleaning, disinfecting, and sterilizing materials using the combination of dense phase gas and ultraviolet radiation |
US7189350B2 (en) * | 1999-12-27 | 2007-03-13 | Kabushiki Kaisha Sr Kaihatsu | Method of sterilizing medical instruments |
US6342528B1 (en) * | 2000-01-18 | 2002-01-29 | Lynntech, Inc. | Control of microbial populations in the gastrointestinal tract of animals |
US6506213B1 (en) * | 2000-09-08 | 2003-01-14 | Ferro Corporation | Manufacturing orthopedic parts using supercritical fluid processing techniques |
US6716457B1 (en) * | 2000-10-17 | 2004-04-06 | Bayer Polymers Llc | Effects of bactericide (peracetic acid-hydrogen peroxide-water combination) to agricultural chemicals in bacteria control when they are in contact with one another |
US7008591B2 (en) * | 2001-10-17 | 2006-03-07 | Edwards Lifesciences Corporation | Supercritical fluid extraction process for tissue preparation |
JP2005511216A (en) * | 2001-12-12 | 2005-04-28 | デピュイ・プロダクツ・インコーポレイテッド | Orthopedic device and manufacturing method thereof |
US6962714B2 (en) * | 2002-08-06 | 2005-11-08 | Ecolab, Inc. | Critical fluid antimicrobial compositions and their use and generation |
WO2005000364A2 (en) * | 2003-06-23 | 2005-01-06 | Novasterilis Inc. | Sterilization methods and apparatus which employ additive-containing supercritical carbon dioxide sterilant |
WO2005001059A2 (en) * | 2003-06-23 | 2005-01-06 | Novasterilis Inc. | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions |
US20100080790A1 (en) * | 2005-07-13 | 2010-04-01 | University Of South Carolina | Sterilization using high-pressure carbon dioxide |
EP1782839A1 (en) | 2005-11-03 | 2007-05-09 | Genetic S.p.A. | Sterilization process of Glucocorticosteroid by supercritical CO2 |
-
2004
- 2004-06-23 WO PCT/US2004/020152 patent/WO2005001059A2/en active Application Filing
- 2004-06-23 US US10/577,050 patent/US7560113B2/en active Active
-
2009
- 2009-06-08 US US12/480,107 patent/US7919096B2/en active Active
-
2010
- 2010-09-23 US US12/888,933 patent/US8388944B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6149864A (en) * | 1998-06-25 | 2000-11-21 | Massachusetts Institute Of Technology | Supercritical fluid sterilization method |
US20030108918A1 (en) * | 2001-09-05 | 2003-06-12 | Castor Trevor P. | Inactivated vaccines for aids and other infectious diseases |
Also Published As
Publication number | Publication date |
---|---|
US20110014184A1 (en) | 2011-01-20 |
US7560113B2 (en) | 2009-07-14 |
US7919096B2 (en) | 2011-04-05 |
US20090246193A1 (en) | 2009-10-01 |
US20070224206A1 (en) | 2007-09-27 |
US8388944B2 (en) | 2013-03-05 |
WO2005001059A2 (en) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005001059A3 (en) | Inactivating organisms using carbon dioxide at or near its supercritical pressure and temperature conditions | |
AU2002234198A1 (en) | Feedforward amplifier | |
AU2003207717B9 (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia | |
ZA200408772B (en) | 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia. | |
AU2001276026A1 (en) | B7-h2 molecules, novel members of the b7 family and uses thereof | |
AU2002302420A1 (en) | 5-phenylpyrimidine, methods and intermediate products for the production thereof and use of the same for controlling pathogenic fungi | |
AU2002258259A1 (en) | Martensitic stainless steel | |
AU2003211120A1 (en) | Removable labels, coupons and the like | |
AU2002951274A0 (en) | Methods for the chemical and physical modification of nanotubes, methods for linking the nanotubes, methods for the directed positioning of nanotubes, and uses thereof | |
AU2003280298A1 (en) | Methods for the biological treatment of gas | |
EP1709157A4 (en) | E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same | |
WO2003005935A3 (en) | Support device with pressure adjustment section and method of use | |
AU2003268271A1 (en) | Valve and retainer assembly for balloon | |
MXPA02007411A (en) | Novel foams and coatings. | |
AU2003264559A1 (en) | Overheat prevention apparatus and gas range having the overheat prevention apparatus | |
HK1045355A1 (en) | Gas seal. | |
PT1591520T (en) | Microorganism producing l-threonine having inactivated tyr gene, method of producing the same and method of producing l-threonine using the microorganism | |
GB2401735B (en) | Differential amplifier, two-stage amplifier including the differential amplifier, and analog-to-digital converter including the differential amplifier | |
AU2003212419A1 (en) | Fluid pressure regulator with stabilizer | |
AU2002364151A1 (en) | Feedforward amplifier | |
AU2003271171A1 (en) | 2,2-DI-SUBSTITUTED 1Alpha,25-DIHYDROXY-19-NORVITAMIN D DERIVATIVE | |
EP1256688A3 (en) | Sealing profile | |
WO2004044170A3 (en) | A pancreatic islet transcription factor and uses thereof | |
PL367700A1 (en) | Identifying parasitic fungi of the organism, and treatment thereof | |
AUPR708801A0 (en) | Potentiation of the microbial lethality of gaseous biocides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 10577050 Country of ref document: US Ref document number: 2007224206 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10577050 Country of ref document: US |